The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Virus is scary, but it's not

Mon, 22nd Jun 2020 11:09

* STOXX erases early losses

* U.S. futures firmly up

* Wirecard plunges again
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

VIRUS IS SCARY, BUT IT'S NOT (1005 GMT)

The virus is still scary, but it's not.

Stocks started in the red after worrying data on the pandemic from the U.S. and from
Germany, but they are now in the black, as investors probably didn't make up their mind yet
about the medium-term trend.

The truth is that the sentiment has been swinging between risk appetite and aversion for
days, and it is probably still bound to do it for a while, unless there is more clarity about
the future of the pandemic and its impact on the economy.

"Fears of a second wave remain key for traders, with the German 'R' rate surging over the
weekend," Joshua Mahony, Senior Market Analyst at IG says.

Then with Europe and UK "loosening the economic shackles, the second half could bring
significant upside surprises for the economy," he adds.

Europe's Stoxx 600 index is now up 0.2%, after losing more than 1% in early trade.

The Stoxx 600 index quickly reversing early losses.

(Stefano Rebaudo)

*****

EU RECOVERY FUND? MAYBE TOO MUCH ENTHUSIASM (0932 GMT)

While everybody agrees that the ECB is in a 'whatever it takes' mood to fight the economic
impact of the virus, investors are a lot more uncertain about the attitude of the European
Union, even after the Commission's big step of proposing a EU recovery fund.

BofA already argued a couple of times that the fiscal stimulus in Europe is not enough to
deliver a healthy economic recovery.

A UBS research note looks at negotiations among EU countries trying to figure out what the
outcome will be after last week's meeting.

UBS analysts sound a lot more cautious than others who cheer the proposed recovery fund as a
big step towards a fiscal union. UBS argues the fund "represents a one-off mutualisation that
leaves the Eurozone's (sharply rising) legacy debt unaffected."

A deal in July is unlikely, but probably it will be in place by the fall, the note says.

Then most importantly, the 500 billion of grants proposed by the EU Commission "might be
reduced," while "rules for conditionality, country allocations and payout periods might be
tightened in a way that might limit" its redistributive impact, it adds.

According to EU preliminary simulations Italy and Spain will be the biggest beneficiaries,
but "we will not be surprised if the final agreement would include caps limiting" the payout for
the biggest recipients.

(Stefano Rebaudo)

*****

OPENING SNAPSHOT: VIRUS FEARS (0726 GMT)

Back in a risk-off mood as the coronavirus pandemic is stealing the stage also today on
worrying data across the world showing more cases.

While the U.S. is still seeing rises in cases and the World Health Organization (WHO) said
the pandemic is accelerating globally, the reproduction rate in Germany jumped to
2.88 on Sunday, above the level needed to contain it over the longer term.

The STOXX 600 is down 0.8%, with the travel and leisure index leading the losses down 2%,
oil and gas down 1.7%.

Lufthansa shares drop by 4.7% ahead of fresh talks about its rescue plan.

Glencore shares are down 5.3% after the company said Swiss prosecutors started a
criminal investigation for failure to have measures in place to prevent alleged corruption in
the Democratic Republic of Congo.

Shares in Deutsche Telekom fall 4.5% as the company goes exdiv this week. The
company said on Friday it will retain control of T-Mobile should Japan's Softbank
liquidate its stake, CEO Tim Hoettges said on Friday as he vowed to claim the top spot
in the U.S. market. DT has a right of first refusal under a four-year shareholder pact.

(Stefano Rebaudo)

*****

ON THE RADAR: WIRECARD, LUFTHANSA (0646 GMT)

European stocks are set to open lower as the virus is back in the spotlight along with
resurging fears that a second wave of shutdowns might weaken an economic recovery globally.

The U.S. sees a rise in cases and the reproduction rate in Germany jumped to 2.88 on Sunday,
above the level needed to contain it over the longer term.

On the corporate front, shares in Wirecard are down 40% in early trade, after the
company said assets totalling 1.9 billion euros ($2.13 billion) that auditor EY has been unable
to account for likely did not exist in the first place. Wirecard also hired U.S.
investment bank Houlihan Lokey to devise a new financing strategy.

Lufthansa shares are down 11% in early trade; its Chief Executive Carsten Spohr
said on Sunday it would seek to avoid a grounding and insolvency, before a showdown between the
airline's biggest shareholder and the German government over the terms of a 9-billion-euro
bailout.

Telefonica CEO Jose Maria Alvarez Pallete said his company will participate in the
consolidation of the sector in "the markets we want to be relevant," according to the Spanish
newspaper Expansion.

Italy is close to unveiling the approval of guarantees for a 6.3 billion euro ($7 billion)
financing of Fiat Chrysler (FCA), two sources familiar with the matter said, paving
the way for the largest crisis loan for a European carmaker.

French airports group ADP risks losing 2.5 billion euros ($2.8 billion) in terms of sales
due to the COVID-19 crisis, ADP's chairman and chief executive Augustin de Romanet told French
newspaper Le Journal du Dimanche in an interview published on Sunday.

GlaxoSmithKline is out of the race to test experimental immunisations against the
coronavirus as it prefers the slow and steady approach of focusing on an established technology,
its chief medical officer for vaccines Thomas Breuer said.

Mediawan announced a raft of deals, including the acquisition of Lagardere Studios,
as part of a broader expansion laid out by its founders, who will also establish a new holding
company for the business.

Atlantia is yet to submit a proposal which the government can accept to solve a row
over its motorway concession but a decision on the matter must be taken soon, Prime Minister
Giuseppe Conte said.

Phoenix Tower International has offered to buy the telecom mast unit of Italy's EITowers
for 550 million euros.

(Stefano Rebaudo)

*****

MORNING CALL: THE VIRUS KEEPS EUROPEAN FUTURES IN THE RED (0538 GMT)

European futures are in the red on fears that a second wave of shutdowns could weaken an
expected economic recovery globally, while its U.S. peers are in positive territory already
showing some resilience after Friday's Wall Street fall.

Apple said on Friday it would shut U.S. stores as coronavirus is on the rise in some states,
triggering a selloff on Wall Street, while according to the World Health Organization (WHO) the
pandemic is accelerating globally.

The coronavirus reproduction rate in Germany jumped to 2.88 on Sunday, taking infections
above the level needed to contain it over the longer term.

Asian stocks edged higher overnight, with Shanghai Composite supported by reforms in its
capital market to help bolster the economy.

(Stefano Rebaudo)

*****

More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.